Sports / Entertainment

Reuters

Cadel Evans poised to win Tour after time trial Los Angeles Times Cadel Evans blazed through Saturday's individual time trial in Grenoble to vault into the overall race lead, grabbing the yellow jersey from Andy Schleck. Evans finished the 42.5-kilometer course in a time of 55:40 — only seven seconds slower than the … Cadel Evans tastes a long-awaited victorymsnbc.com Cadel Evans Set to Become 1st Aussie to Win TourABC News Schlecks content with double podium finish on TourReuters Bloomberg -ABC Online -Cyclingnews.com all 3,079 news articles »

Sports – Google News

ABC News

Clemens' path to trial FOXSports.com 1993: Brian McNamee, then a New York City cop, hired as a bullpen catcher by the New York Yankees, a job he held until 1995. During that time, he began to train “Olympic-caliber athletes” on the side. 1998: McNamee was hired by the Toronto Blue Jays as … Jury selection to begin in perjury trial of baseball's Roger ClemensCNN Clemens' attorney one of the bestESPN Clemens' trial unlikely to hear ex-Yanks' drug useCecil Whig Christian Science Monitor -Deseret News -New York Times all 944 news articles »

Sports – Google News

CBC.ca

Casey Anthony Trial: Jury Begins Deliberations ABC News Casey Anthony at the defense table on the final day of arguments in her murder trial in Orlando, Fla., July 4, 2011. (Red Huber, Orlando Sentinel) Jurors in the Casey Anthony trial have begun deliberating the fate of … Casey Anthony murder trial goes to jury in FloridaReuters Casey Anthony trial: State wraps up its caseChicago Tribune Casey Anthony Trial Update: Case goes to the juryCBS News Tbo.com -WPBF West Palm Beach -Christian Post all 2,140 news articles »

Sports – Google News

Fox News

Win or lose, Heat's trial by Finals good for everyone CBSSports.com As Dirk Nowitzki made his way to the interview room, he passed a middle-aged man with salt-and-pepper hair in the hallway of the arena. It was Micky Arison, the owner of the Heat. Arison gazed up at the Mavericks' 7-foot giant, … Rare photos of Jason KiddSI.com End of the line for Miami Heat?ESPN Questions Will Hound James Till He Wins a TitleNew York Times FOX 4 News -HoopsWorld -Dallas Morning News (subscription) all 7,437 news articles »

Sports – Google News

Marina Biotech Announces First Patient Enrollment in Familial Adenomatous Polyposis Clinical Trial
CEQ508 Is the First Oral RNAi-Based Therapeutic to Enter Human Clinical Studies

Read more on Marketwire

QPS Expands Clinical Trial Services with Acquisition of Qualitix
Broadens later stage capabilities and Increases Asian presence

Read more on Thaipr.net

Isis Pharma announces ISIS-CRPRx Phase 1 trial results in diseases with elevated CRP
Isis Pharmaceuticals, Inc. announced today the results from a Phase 1 clinical trial in which ISIS-CRPRx produced statistically significant reductions in C-reactive protein in the cohort of subjects in the study with elevated CRP.

Read more on News-Medical-Net

Genentech initiates GDC-0449 Phase II clinical trial in BCC patients
Curis, Inc. a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell …

Read more on News-Medical-Net

Baxter Presents Data from Interim Analyses of Phase III Clinical Trial of HyQ at European Society for …
Data from interim analyses of a Phase III clinical study in patients with primary immune deficiency who received Baxter’s HyQ were presented at the 26th meeting of the European Society for Immunodeficiencies in Istanbul, Turkey.

Read more on Business Wire via Yahoo! Finance

Two-Year Data from Phase 2 Trial of Genzyme’s Eliglustat Tartrate for Gaucher Disease To Be Published in the Journal …
CAMBRIDGE, Mass.—-Genzyme Corporation announced today that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal Blood.

Read more on Business Wire via Yahoo! Finance